KaloBios Pharmaceutical files for bankruptcy

Published Wed, Dec 30, 2015 · 10:02 AM

[BENGALURU] KaloBios Pharmaceuticals Inc, which fired its controversial chief executive, Martin Shkreli, earlier this month, filed for Chapter 11 bankruptcy on Tuesday in the US bankruptcy court for the District of Delaware.

The drugmaker listed both its assets and liabilities in the range of US$1 million to US$10 million.

The move comes on the heels of KaloBios' appeal of the Nasdaq decision to delist its shares.

REUTERS

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes

Consumer & Healthcare

Marina Bay Sands Q1 profit surges 51.5% to US$597 million on tourism boom
Swiss watch exports plunge as China and Hong Kong demand dries up
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO
Billionaires selling cheap stuff get richer from inflation pain
Amazon to push cashierless shopping tech into more third-party stores, while backing off itself
Japan’s Uniqlo opens Rome store as part of European expansion

Companies & Markets

KaloBios Pharmaceutical files for bankruptcy

Consumer & Healthcare

Marina Bay Sands Q1 profit surges 51.5% to US$597 million on tourism boom

Swiss watch exports plunge as China and Hong Kong demand dries up

Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO

Billionaires selling cheap stuff get richer from inflation pain

Amazon to push cashierless shopping tech into more third-party stores, while backing off itself

Japan’s Uniqlo opens Rome store as part of European expansion

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

SECTIONS

LIFESTYLE

Follow BT